Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Indiscriminate and irrational use of antibiotics has led to the emergence of antibiotic resistance of Salmonellatyphi (S. typhi) and the rapid spread of extended-spectrum beta-lactamase (ESBL) producing strains conferring resistance. This is in fact worrisome, is threatening antibiotic therapy and placing a substantial clinical and financial burden on the healthcare system, patients and their families. Aim of research was to detect molecularly extended-spectrum beta-lactamase producing S. typhi isolates in patients attending Bingham University Teaching Hospital (BhUTH), Jos, Plateau State, North-Central Nigeria. A total of 353stool samples were collected from patients attending BhUTH, and identified using standard microbiological techniques. Antibiotics susceptibility testing was carried out using disc diffusion method, and double disc synergy test (DDST) for phenotypic ESBL production. Polymerase Chain Reaction (PCR) and agarose gelelectrophoresis were done to detect the presence of ESBL genes. S. typhi prevalence was 37(10.4%). Antibiotics susceptibility profile showed highest resistance to Augmentin and Ampicillin (100%) and less resistance to Nitrofurantoin (0%) and Cefuroxime (24.3%). The S. typhi isolates had CRX-AUG-AMP-AMX-STR-CH and CRX-AUG-AMP-AMX-STR as the most frequent resistant phenotypes (10.8%) with multidrug-resistant (MDR) isolates (73%). ESBL producing isolates were 5(13.5%). PCR and agarose gel electrophoresis confirmed the presence of blaCTX-M 2(40.0%), blaSHV 3(60.0%) and blaTEM 5(100.0%) on 857, 615, and 972 base pairs respectively. S. typhi isolates showed higher susceptibility to Nitrofurantoin and Cefuroxime. Prompt monitoring of antibiotics usage, resistance to antibiotics and public health education are therefore necessary in order to reduce bacterial disease burden.
Indiscriminate and irrational use of antibiotics has led to the emergence of antibiotic resistance of Salmonellatyphi (S. typhi) and the rapid spread of extended-spectrum beta-lactamase (ESBL) producing strains conferring resistance. This is in fact worrisome, is threatening antibiotic therapy and placing a substantial clinical and financial burden on the healthcare system, patients and their families. Aim of research was to detect molecularly extended-spectrum beta-lactamase producing S. typhi isolates in patients attending Bingham University Teaching Hospital (BhUTH), Jos, Plateau State, North-Central Nigeria. A total of 353stool samples were collected from patients attending BhUTH, and identified using standard microbiological techniques. Antibiotics susceptibility testing was carried out using disc diffusion method, and double disc synergy test (DDST) for phenotypic ESBL production. Polymerase Chain Reaction (PCR) and agarose gelelectrophoresis were done to detect the presence of ESBL genes. S. typhi prevalence was 37(10.4%). Antibiotics susceptibility profile showed highest resistance to Augmentin and Ampicillin (100%) and less resistance to Nitrofurantoin (0%) and Cefuroxime (24.3%). The S. typhi isolates had CRX-AUG-AMP-AMX-STR-CH and CRX-AUG-AMP-AMX-STR as the most frequent resistant phenotypes (10.8%) with multidrug-resistant (MDR) isolates (73%). ESBL producing isolates were 5(13.5%). PCR and agarose gel electrophoresis confirmed the presence of blaCTX-M 2(40.0%), blaSHV 3(60.0%) and blaTEM 5(100.0%) on 857, 615, and 972 base pairs respectively. S. typhi isolates showed higher susceptibility to Nitrofurantoin and Cefuroxime. Prompt monitoring of antibiotics usage, resistance to antibiotics and public health education are therefore necessary in order to reduce bacterial disease burden.
Tuberculosis (TB) is of grave public health concern globally with a reported 1.3 million deaths approximately, caused by the infection. TB infection is closely associated with depression which at its worst stage can bring up suicidal thoughts and death. This study aimed to assess knowledge, attitude, and factors associated with depression in TB patients attending Directly Observed Treatment Short course (DOTS) centers in Lagos State, South-West Nigeria. A descriptive, cross-sectional approach was used to evaluate responses from 301 TB patients at 8 DOTS centers in Lagos State. Data from the participants (respondents) was collected using interviewer-administered questionnaires. Patient Health Questionnaire-9 (PHQ-9) was used to determine the depression status of the participants. Obtained data was analyzed using SPSS version 23.0, with the Chi-square test being used to check for the association of selected factors with the depression status of the participants. The mean age of the respondents was 35.1±11.7 years. A majority (71.8%) of the respondents were males, 69.1% were Christians, Yorubas were most (52.2%), 88.4% earned <N150,000 monthly, and only 1 participant had no formal education. Knowledge of depression among the participants was average (fair) and the attitude was positive among 41% of them. Factors significantly associated with depression were the presentation of symptoms, drug therapy duration, stigma from family and friends, denial of privileges, HIV status, privacy during treatment, and family support (p<0.05). Factors like the thought that tuberculosis makes one depressed, period of being diagnosed, stage of treatment, distance to the treatment center, attitude of the treatment center staff, and time spent on a treatment day were significantly not associated with depression (p>0.05). Depression can be fatal. Therefore, TB patients receiving treatment should be well-enlightened about this mental disorder.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.